These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7185616)

  • 1. Species differences in kidney toxicity and metabolic activation of tris(2,3-dibromopropyl)phosphate.
    Søderlund EJ; Nelson SD; von Bahr C; Dybing E
    Fundam Appl Toxicol; 1982; 2(4):187-94. PubMed ID: 7185616
    [No Abstract]   [Full Text] [Related]  

  • 2. Nephrotoxicity of the flame retardant, tris(2,3-dibromopropyl) phosphate, and its metabolites.
    Elliott WC; Lynn RK; Houghton DC; Kennish JM; Bennett WM
    Toxicol Appl Pharmacol; 1982 Jan; 62(1):179-82. PubMed ID: 7064152
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative genotoxicity and nephrotoxicity studies of the two halogenated flame retardants tris(1,3-dichloro-2-propyl)phosphate and tris(2,3-dibromopropyl)phosphate.
    Søderlund EJ; Dybing E; Holme JA; Hongslo JK; Rivedal E; Sanner T; Nelson SD
    Acta Pharmacol Toxicol (Copenh); 1985 Jan; 56(1):20-9. PubMed ID: 3883695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative genotoxicity studies of the flame retardant tris(2,3-dibromopropyl)phosphate and possible metabolites.
    Holme JA; Søderlund EJ; Hongslo JK; Nelson SD; Dybing E
    Mutat Res; 1983 Dec; 124(3-4):213-24. PubMed ID: 6686285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrotoxic effect of tris(2,3-dibromopropyl)phosphate on rat urinary metabolites: assessment from 13C-NMR spectra of urines and biochemical and histopathological examinations.
    Fukuoka M; Takahashi T; Tanaka A; Yamaha T; Naito K; Nakaji Y; Kobayashi K; Tobe M
    J Appl Toxicol; 1987 Feb; 7(1):23-34. PubMed ID: 3611594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism, distribution, and excretion of the flame retardant, tris(2,3-dibromopropyl) phosphate (tris-bp) in the rat: identification of mutagenic and nephrotoxic metabolites.
    Lynn RK; Garvie-Gould C; Wong K; Kennish JM
    Toxicol Appl Pharmacol; 1982 Mar; 63(1):105-19. PubMed ID: 7071866
    [No Abstract]   [Full Text] [Related]  

  • 7. Nephrotoxicity of the flame retardant tris(2,3-dibromopropyl)phosphate.
    Dybing E; Søderlund E
    Arch Toxicol Suppl; 1980; 4():219-22. PubMed ID: 6933906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative studies on nephrotoxic effects of tris (2,3-dibromopropyl) phosphate and bis (2,3-dibromopropyl) phosphate on rat urinary metabolites.
    Fukuoka M; Takahashi T; Naito K; Takada K
    J Appl Toxicol; 1988 Feb; 8(1):43-52. PubMed ID: 3356864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation mechanism of tris(2,3-dibromopropyl)phosphate to the potent mutagen, 2-bromoacrolein.
    Nelson SD; Omichinski JG; Iyer L; Gordon WP; Soderlund EJ; Dybing E
    Biochem Biophys Res Commun; 1984 May; 121(1):213-9. PubMed ID: 6375666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tris (2,3-dibromopropyl) phosphate nephrotoxicity in the rat: histological and biochemical changes in renal components by 13C-NMR spectra.
    Fukuoka M; Tanaka A; Yamaha T; Naito K; Takada K; Kobayashi K; Tobe M
    J Appl Toxicol; 1988 Dec; 8(6):411-6. PubMed ID: 3230254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism in vitro of tris(2,3-dibromopropyl)-phosphate: oxidative debromination and bis(2,3-dibromopropyl)phosphate formation as correlates of mutagenicity and covalent protein binding.
    Søderlund EJ; Gordon WP; Nelson SD; Omichinski JG; Dybing E
    Biochem Pharmacol; 1984 Dec; 33(24):4017-23. PubMed ID: 6508849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic activation of bromopropyl compounds.
    Dybing E; Söderlund EJ; Nelson SD
    Adv Exp Med Biol; 1981; 136 Pt A():647-54. PubMed ID: 7046380
    [No Abstract]   [Full Text] [Related]  

  • 13. Tris(2-chloroethyl) phosphate.
    IARC Monogr Eval Carcinog Risks Hum; 1990; 48():109-20. PubMed ID: 2197455
    [No Abstract]   [Full Text] [Related]  

  • 14. Rat teratology study of orally administered tris-(2,3-dibromopropyl) phosphate.
    Seabaugh VM; Collins TF; Hoheisel CA; Bierbower GW; McLaughlin J
    Food Cosmet Toxicol; 1981 Feb; 19(1):67-72. PubMed ID: 7262733
    [No Abstract]   [Full Text] [Related]  

  • 15. Mutagenicity of bis- and mono-(2,3-dibromopropyl)phosphate, and their salts used as flame retardants, in the Salmonella/microsome system.
    Nakamura A; Tateno N; Iwata T; Kojima S; Kaniwa M; Kawamura T
    Mutat Res; 1983 Apr; 117(1-2):1-8. PubMed ID: 6339901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro biological effects of the flame retardants tris(2,3-dibromopropyl) phosphate and tris(2-chlorethyl)orthophosphate.
    Sala M; Gu ZG; Moens G; Chouroulinkov I
    Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1337-44. PubMed ID: 6891932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrotoxicity and hepatotoxicity of tris(2,3-dibromopropyl)phosphate in the rat.
    Söderlund E; Dybing E; Nelson SD
    Toxicol Appl Pharmacol; 1980 Nov; 56(2):171-81. PubMed ID: 7466817
    [No Abstract]   [Full Text] [Related]  

  • 18. Another flame retardant, tris-(1,3-dichloro-2-propyl)-phosphate, and its expected metabolites are mutagens.
    Gold MD; Blum A; Ames BN
    Science; 1978 May; 200(4343):785-7. PubMed ID: 347576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new mutagenic and genotoxic response of the flame retardant tris(2,3-dibromopropyl)phosphate. Activation by singlet oxygen.
    McCoy E; Hyman J; Rosenkranz HS
    Mutat Res; 1980 Mar; 77(3):209-14. PubMed ID: 6991918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity studies on the mutagenicity of tris(2,3-dibromopropyl) phosphate (Tris-BP) and its metabolites in Salmonella.
    Zeiger E; Pagano DA; Nomeir AA
    Environ Mutagen; 1982; 4(3):271-7. PubMed ID: 7094911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.